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Abstract
Recent evidences indicate that triple-negative breast cancer (TNBC) cells with a mesenchymal phenotype show a basal
activation of the unfolded protein response (UPR) that increases their sensitivity to endoplasmic reticulum (ER) stress
although the underlying cell death mechanism remains largely unexplored. Here we show that both caspase-8-
dependent and -independent apoptotic mechanisms are activated in TNBC cells undergoing sustained ER stress.
Activation of the extrinsic apoptotic pathway by ER stress involves ATF4-dependent upregulation of tumor necrosis
factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2/DR5). In addition, accumulation of BH3-only protein
Noxa at the mitochondria further contributes to apoptosis following ER stress in TNBC cells. Accordingly, simultaneous
abrogation of both extrinsic and intrinsic apoptotic pathways is required to inhibit ER stress-induced apoptosis in
these cells. Importantly, persistent FLICE-inhibitory protein (FLIP) expression plays an adaptive role to prevent early
activation of the extrinsic pathway of apoptosis upon ER stress. Overall, our data show that ER stress induces cell death
through a pleiotropic mechanism in TNBC cells and suggest that targeting FLIP expression may be an effective
approach to sensitize these tumor cells to ER stress-inducing agents.
Introduction
Physiological or pathological alterations in the cellular
environment can disrupt the protein folding capacity of
the endoplasmic reticulum (ER), causing ER stress1. In
vertebrates, accumulation of unfolded proteins in the ER
lumen is detected by three different types of protein
sensors2–4 located in the luminal face of the ER membrane
that activate an adaptive response known as the unfolded
protein response (UPR)5 to restore protein homeostasis in
the ER. Activation of these signaling pathways leads to a
reduction in the inﬂux of proteins into the ER, activates
protein degradation pathways, and increases the folding
capacity of the ER5. However, under severe or sustained
ER stress some of the UPR signaling pathways will activate
a cell death process by engaging the apoptotic machin-
ery6,7. Upregulation of proapoptotic proteins and down-
regulation of antiapoptotic proteins of the Bcl-2 family
have been observed in cells undergoing apoptosis upon
ER stress8–10. In addition, upregulation of tumor necrosis
factor-related apoptosis-inducing ligand receptor 2
(TRAIL-R2/DR5) expression and activation of the
extrinsic apoptotic pathway following ER stress has also
been demonstrated11–13. However, whether or not both
intrinsic and extrinsic apoptotic pathways are activated
simultaneously and the relative contribution of each
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pathway to apoptosis in cells undergoing ER stress is an
issue that remains largely unresolved.
Triple-negative breast cancer (TNBC) is a hetero-
geneous disease representing 10–20% of cases of breast
tumors, characterized by the absence of estrogen recep-
tors (ER−) and progesterone receptors (PR−) and lack of
human epidermal growth factor type 2 receptor gene
ampliﬁcation14. TNBC has poor prognosis and a high rate
of early relapse and still pose a major challenge in cancer
management, being conventional chemotherapy the only
therapeutic option15. It has been recently reported that
TNBC cells with a mesenchymal phenotype secrete a
greater amount of extracellular matrix proteins relative to
non-mesenchymal cells and present basal levels of UPR
activation16. Under these conditions, triggering the UPR
may facilitate tumor cell survival and growth by increasing
the expression of the ER chaperones, reducing the load of
new synthesized proteins in the ER lumen, and by acti-
vating ER-associated degradation of unfolded proteins17.
However, mesenchymal TNBC cells are markedly sensi-
tive to apoptosis induced by different ER stress stimuli,16
although the mechanism underlying this cell death upon
ER stress has not been elucidated.
In this work, we sought to determine the relative con-
tribution of the extrinsic and intrinsic apoptotic pathways
to the induction of cell death upon sustained ER stress in
TNBC cells. Our results showed that both activating
transcription factor-4 (ATF4)/TRAIL-R2/caspase-8 and
Noxa-mediated pathways are involved in the cell death
process induced by ER stress in TNBC cells. Our results
also demonstrated that maintenance of cellular FLICE-
inhibitory protein (FLIP) levels following ER stress plays
an adaptive role to prevent early activation of the extrinsic
apoptotic pathway in these tumor cells.
Results
ER stress induces cell death in TNBC cells through a
mitochondria-operated apoptotic pathway
We ﬁrst evaluated the sensitivity of different TNBC and
non-TNBC cell lines to ER stress-induced apoptosis.
Dose–response experiments with thapsigargin, a well-
known ER stress inducer, show that TNBC cell lines of
basal phenotype are more sensitive than luminal tumor
cell lines to treatment with thapsigargin for 72 h (Fig. 1A)
as previously reported16. We also determined the kinetics
of apoptosis induced by thapsigargin in TNBC and non-
TNBC cell lines. As shown in Fig. 1B, apoptosis was
induced in TNBC cell lines MDA-MB231 and BT549 after
48 and 72 h treatment, respectively. In contrast, the non-
TNBC cell line T47D was markedly resistant to
thapsigargin-induced apoptosis. Cell death induced by
thapsigargin was strongly inhibited in two TNBC cell
lines, MDA-MB231 and BT549, when treated in the
presence of the pan-caspase inhibitor Z-VAD-fmk
(Fig. S1A). Likewise, cell death provoked by ER stress
inducer tunicamycin was abrogated in the presence of the
general caspase inhibitor Q-VD-OPh in both TNBC cell
lines (Fig. S1B), further indicating the activation of
caspase-dependent cell death upon ER stress in TNBC
cells. Consistent with these ﬁndings, we also found the
processing of various caspases and the loss of BH3-only
protein Bid in MDA-MB231 cells treated with thapsi-
gargin and not in cells of the non-TNBC cell line T47D
(Fig. 1C).
To further characterize the mechanism underlying ER
stress-induced apoptosis in TNBC cells, we assessed the
role of the mitochondria-operated cell death pathway in
apoptosis upon ER stress in MDA-MB231 cells ectopically
expressing the antiapoptotic protein of the Bcl-2 family,
Bcl-XL (231-Bcl-XL). As shown in Fig. 1D, activation of
apoptosis by ER stress inducers occurred through a
mitochondria-operated pathway as it was substantially
inhibited in 231-Bcl-XL cells.
Role of the intrinsic and extrinsic apoptotic pathways in
cell death induced by ER stress in TNBC cells
To assess the role of the Bcl-2 protein family in cell
death regulation by ER stress in TNBC cells, we deter-
mined by RT-MLPA (retro transcription-multiplex ligand
probe-dependent ampliﬁcation) the expression levels of
proapoptotic genes of the Bcl-2 family in MDA-MB231
and T47D cells treated with thapsigargin. Results of these
experiments showed little variation in the messenger RNA
(mRNA) expression levels of BH3-only and multi-domain
proapoptotic proteins in response to thapsigargin
(Fig. 2A). Interestingly, basal mRNA levels of proa-
poptotic genes such as Noxa, BNIP3, and BAX were
clearly higher in ER stress-sensitive MDA-MB231 cells as
compared to resistant T47D cells (Fig. 2A). As Noxa has
been demonstrated to play a role in ER stress-induced
apoptosis18,19, we determined the protein levels of Noxa
in both MDA-MB231 and T47D cell lines in response to
thapsigargin. As shown in Fig. 2B, TNBC MDA-MB231
cells express detectable Noxa protein levels, which were
clearly upregulated following thapsigargin treatment. In
contrast, in the non-TNBC breast tumor cell line T47D
Noxa levels were undetectable, even after treatment with
thapsigargin. To assess the role of BH3-only proteins in
ER stress-induced apoptosis in TNBC cells, we silenced
the expression of Noxa as well as other two BH3-only
proteins that have been implicated in ER stress-induced
cell death: Bim and Puma9,18. Despite a marked reduction
in the target mRNA o protein levels (Fig. 2C, left panels),
we only observed a slight inhibitory effect of Noxa small
interfering RNA (siRNA) and no signiﬁcant effect of
Puma and Bim siRNAs on thapsigargin-induced apoptosis
(Fig. 2C, right panel). Furthermore, simultaneous knock-
down of Noxa, Bim, and Puma did not signiﬁcantly reduce
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apoptosis upon thapsigargin treatment (Fig. S1C). Taken
together, all these results suggest that the requirement of
the mitochondrial apoptotic pathway in the activation of
apoptosis by ER stress in TNBC cells does not depend
exclusively on the expression of the BH3-only proteins
Noxa, Bim, or Puma.
Protein kinase RNA-like ER kinase (PERK), a trans-
membrane kinase of the ER phosphorylates eukaryotic
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Fig. 1 ER stress induces apoptosis speciﬁcally in TNBC cells through a mitochondria-operated pathway. Apoptosis was measured after 3 days
of treatment by subG1 analysis as described under Materials and methods section. Error bars represent standard error of the mean (SEM) from at least
three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001. A) Dose–response of thapsigargin (TG) in apoptosis in TNBC (red lines) and non-
TNBC (blue lines) cells. B) Kinetics of apoptosis induction by TG (100 nM) in TNBC (MDA-MB231 and BT549) and non-TNBC (T47D) cell lines.
C) MDA-MB231 and T47D were treated with TG (100 nM) for the indicates times. Kinetics of caspase processing and Bid loss were determined in
whole-cell extracts by western blotting. Tubulin levels were used as protein-loading controls. D) Apoptosis was assessed in Bcl-XL-overexpressing
MDA-MB231 cells treated with 100 nM TG or 1 µg/ml tunicamycin (TN). Bcl-XL expression was assessed by western blotting. Tubulin expression was
used as a protein-loading control
Cano-González et al. Cell Death and Disease  (2018) 9:134 Page 3 of 16
Ofﬁcial journal of the Cell Death Differentiation Association
Fig. 2 (See legend on next page.)
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initiation factor 2α upon ER stress to attenuate general
protein synthesis by inhibiting mRNA translation, thus
reducing the protein burden in ER. However, translation
of certain transcripts such as the mRNA for transcription
factor ATF4 is favored under ER stress to activate an
adaptive response20. After chronic ER stress, ATF4 is also
involved in ER stress-induced apoptosis through the
induction of transcription factor CAAT/enhancer binding
protein homologous protein (CHOP)21. It has been
reported that the proapoptotic function of the ATF4/
CHOP axis involves the transcriptional regulation of
various target genes including GADD34 phosphatase and
ERO1alpha oxidase, which increases global protein
synthesis and production of reactive oxygen species
(ROS), respectively, leading to proteotoxicity in stressed
cells22. However, treatment of MDA-MB231 cells with
thapsigargin in the presence of the GADD34 phosphatase
inhibitor salubrinal23 did not reduce the levels of apop-
totic cells (Fig. S2A). Likewise, treatment of MDA-MB231
cells with thapsigargin in the presence of N-acetyl-
cysteine, an antioxidant that decreases ROS and oxidative
stress, did not inhibit apoptosis (Fig. S2B).
A potential CHOP-binding site has been identiﬁed in
the promoter region of the proapoptotic TRAIL-R2/DR5
gene12, whose induction in response to ER stress has been
observed in different tumor cell lines11–13. As shown in
Fig. 2D (left panel), treatment of MDA-MB231 cells with
thapsigargin markedly upregulated TRAIL-R2/DR5
expression at the cell surface. To examine the role of the
TRAIL-R2-mediated signaling in ER stress-induced
apoptosis in TNBC cells, we silenced the expression of
the key proteins involved in the early signaling of TRAIL:
TRAIL-R2/DR5, FADD, and caspase 8, prior to incuba-
tion with the ER stress inducer (Fig. 2D, left and middle
panels). However, knockdown of any of these proteins of
the extrinsic pathway of apoptosis did not block
thapsigargin-induced apoptosis in MDA-MB231 cells
(Fig. 2D, right panel). Likewise, knockdown of caspase-8
expression did not abrogate ER stress-induced apoptosis
in MDA-MB231 cells treated either with dithiothreitol
(DTT) or tunicamycin (Fig. S2C), two well-known indu-
cers of ER stress. These results were further corroborated
in the BT549 cell line, another TNBC cell line, in which
silencing caspase-8 expression did not reduce ER stress-
induced apoptosis (Fig. S2D).
Simultaneous inhibition of the extrinsic and intrinsic
apoptotic pathways prevents ER stress-induced apoptosis
in TNBC cells
Given that, individually, none of the two major apop-
totic pathways appeared to be involved in the regulation
of cell death by ER stress, we determined the effect of
inhibiting simultaneously both pathways on apoptosis
induced by ER stress. Interestingly, combined silencing of
Noxa and TRAIL-R2 expression, but not TRAIL-R1, sig-
niﬁcantly inhibited thapsigargin-induced apoptosis
(Fig. 3A), further supporting a role of both intrinsic and
extrinsic apoptotic pathways in cell death upon ER stress
in MDA-MB231 cells. Importantly, though thapsigargin
treatment induced the expression of TRAIL in MDA-
MB231 cells (Fig. S3A), simultaneous silencing of TRAIL
and Noxa did not prevent apoptosis upon ER stress
(Fig. S3B), thus suggesting the activation of a ligand-
independent apoptotic mechanism. Strikingly, simulta-
neous knockdown of Noxa and caspase-8 expression in
MDA-MB231 cells substantially inhibited thapsigargin-
induced apoptosis (Fig. 3B), which was not further
reduced if PUMA expression was also silenced (Fig. 3B).
In addition, combined silencing of Noxa and Bid, a BH3-
only protein responsible for the ampliﬁcation of death
receptor signals by triggering the mitochondrial pathway
of apoptosis24, resulted in a signiﬁcant inhibition of
thapsigargin-induced apoptosis (Fig. 3C). Further evi-
dences for the involvement of both intrinsic and extrinsic
pathways in thapsigargin-induced apoptosis were
obtained from the analysis of caspase-8 processing in cells
overexpressing Bcl-XL. In these cells, caspase-9 and
caspase-3 activation upon thapsigargin treatment were
(see ﬁgure on previous page)
Fig. 2 Role of the Bcl-2 protein family in cell death induced by ER stress. A) MDA-MB231 and T47D breast cancer cells were treated with or
without 100 nM thapsigargin (TG) for 20 h. The expression of Bcl-2 family genes was examined by RT-MLPA as described in materials and methods
section. Error bars represent SD (n = 3) of the mRNA expression levels normalized by beta-2-microglobulin. B) Cells were treated with or without TG
100 nM for 24 h. Whole-cell extracts were prepared and Noxa expression was determined by western blotting. GAPDH expression was used as a
protein-loading control. C) MDA-MB231 cells were either non-transfected (NT) or transfected with siRNAs for 30 h prior to treatment with 50 nM TG
for 15 h. Noxa and Bim protein levels were assessed by western blotting. Puma mRNA levels was determined by RT-qPCR. Apoptosis was assessed in
NT and transfected cells after 48 h of TG treatment (50 nM). Error bars represent SEM from at least three independent experiments. **P < 0.01; n.s. not
statistically signiﬁcant. D) MDA-MB231 cells were either NT or transfected with siRNAs for 30 h. TRAIL-R2 cell surface levels were determined by ﬂow
cytometry with TRAIL-R2-PE antibody as described in the material and methods section (left panel). Cells incubated with control IgG-PE antibody
were used as a control for background ﬂuorescence. Caspase-8, TRAIL-R2, and FADD levels were assessed by western blotting (middle panel). Data
shown are representative of three independent experiments. In parallel, cultures of NT and siRNA-transfected cells were treated with 50 nM TG for 48
h, and apoptosis was determined by subG1 analysis (right panel). Error bars represent SEM from at least three independent experiments. n.s. not
statistically signiﬁcant
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Fig. 3 Simultaneous inhibition of the intrinsic and extrinsic apoptotic pathways blocks thapsigargin-induced apoptosis in TNBC cells.
MDA-MB231 cells were either non-transfected (NT) or transfected with the indicated siRNAs for 30 h to determine the role of A) TRAIL receptors
(TRAIL-R1 and TRAIL-R2), B) caspase-8 (casp8) and C) Bid in apoptosis upon ER stress. Knockdown efﬁciency was determined by either western
blotting or RT-PCR. Parallel cultures of NT or siRNA-transfected cells were then treated with 50 nM thapsigargin (TG) for 48 h, and apoptosis was then
determined. Error bars represent SEM from at least three independent experiments. *P < 0.05; ***P < 0.001; n.s. not statistically signiﬁcant
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markedly inhibited as compared to control pbabe cells
(Fig. S3C). Importantly, although reduced, caspase-8
processing was still observed in thapsigargin-treated Bcl-
XL cells (Fig. S3C), these data suggesting the activation of
caspase-8 upstream of mitochondria through death
receptor activation. Supporting these data, similar results
were obtained in cells treated with TRAIL (Fig. S3D).
Thus apoptosis (upper panel) and caspase-8 processing
(lower panel) induced by TRAIL were signiﬁcantly
reduced in Bcl-XL cells (Fig. S3B). Together, these results
indicate a dual activation of caspase-8 upon ER stress in
MDA-MB231 cells, upstream of mitochondria following
death receptor activation and downstream of mitochon-
dria possibly through a caspase-9/caspase-3 axis. Collec-
tively, these results reveal that, in TNBC cells, ER stress
leads to the simultaneous activation of both intrinsic and
ligand-independent, TRAIL-R2-dependent extrinsic
apoptotic pathways, any of which is sufﬁcient to kill the
cells through a mitochondria-operated mechanism.
Role of UPR sensors in ER stress-induced apoptosis in TNBC
cells
To further characterize the mechanism underlying the
differential sensitivity of TNBC and non-TNBC cells to ER
stress inducers, we examined the activation state of two
branches of the UPR that are known to regulate cell fate
under ER stress conditions1. Thus expression of ATF4 and
its target gene CHOP were signiﬁcantly upregulated by
thapsigargin in MDA-MB231 cells as compared to what
was observed in non-TNBC T47D cells (Fig. 4A). In addi-
tion, activation of the inositol-requiring protein-1 (IRE1)
branch of the UPR, as determined by the processing of the
mRNA encoding the transcription factor X box-binding
protein 1 (XBP1u) (Fig. 4B), was markedly induced in
MDA-MB231 cells. In contrast, processing of transcription
factor XBP1u was not observed in T47D cells (Fig. 4B).
These results conﬁrmed a differential activation of the UPR
between ER stress-sensitive and -resistant cell lines.
We next sought to determine the role of the UPR
branches in apoptosis induced by ER stress-inducing
agents in TNBC cells. We observed that transfection of
MDA-MB231 cells with speciﬁc siRNAs for ATF4 and
CHOP markedly inhibited ER stress-induced upregulation
of these proteins (Fig. 4C, right panel): However, silencing
ATF4 or CHOP expression did not reduce apoptosis
induced by thapsigargin (Fig. 4C, left panel). As the
proapoptotic role of IRE1 could be mediated in part by
the activation of Jun N-terminal kinase (JNK) signaling25,
we determined the effect of a JNK-speciﬁc inhibitor in
apoptosis induced by ER stress in MDA-MB231 cells.
Results shown in Fig. S4A indicate that inhibition of JNK
activity did not prevent apoptosis induced upon thapsi-
gargin treatment in MDA-MB231 cells. In addition, IRE1
knockdown (Fig. 4D, right panel) completely abrogated
XBP1u processing (Fig. 4D, bottom panels) but did not
inhibit apoptosis induced by thapsigargin (Fig. 4D, left
panel). Furthermore, simultaneous inhibition of the PERK
and IRE1 pathways had no effect on ER stress-induced
apoptosis (Fig. S4B). Conﬁrming these results, combined
knockdown of IRE1 and proteins of the extrinsic (Cas-
pase-8) or intrinsic (Noxa) apoptotic pathways did not
inhibit thapsigargin-induced apoptosis in MDA-MB231
cells (Fig. S4C). Finally, silencing the expression of UPR
sensor activating transcription factor-6 (ATF6) did not
result in a reduction of apoptosis induced by thapsigargin
(Fig. S4D).
Next, we determined the impact of inhibiting the PERK/
ATF4/CHOP pathway on the expression of TRAIL-R2/
DR5, a key effector in the activation of apoptosis upon ER
stress in different cell systems11–13. Thapsigargin treat-
ment elevated TRAIL-R2/DR5 protein expression
(Fig. 5A, right panel) and cell surface levels (Fig. 5A, left
panel) in both MDA-MB231 and BT549 cell lines but not
in the ER stress-resistant T47D breast tumor cell line.
Interestingly, ATF4 knockdown by siRNA prevented
TRAIL-R2 upregulation upon thapsigargin treatment in
MDA-MB231 cells (Fig. 5B). Although ATF4 may induce
Noxa expression and thus triggers the intrinsic pathway of
apoptosis in different systems18,19,26, ATF4 silencing did
not signiﬁcantly affect Noxa levels in thapsigargin-treated
MDA-MB231cells (Fig. 5B). Collectively, these results
indicate that, in the TNBC cells, the PERK pathway is
responsible for the regulation of the extrinsic pathway of
apoptosis upon ER stress while it does not seem to have a
role in the pathway controlling Noxa levels.
The above data prompted us to investigate whether
simultaneous activation of the PERK/ATF4 and the Noxa-
regulated pathways may be responsible for the observed
induction of apoptosis upon ER stress in TNBC cells.
Although knockdown of either Noxa or ATF4 expression
did not affect the sensitivity of MDA-MB231 cells to
thapsigargin, combined silencing of both proteins sig-
niﬁcantly reduced apoptosis upon ER stress (Fig. 5C). On
the contrary, simultaneous silencing of ATF4 and
caspase-8 expression did not alter the sensitivity of MDA-
MB231 cells to thapsigargin (Fig. 5C), further indicating
that both proteins belongs to the same apoptotic pathway.
To get further insight into the mechanism underlying
Noxa-mediated activation of apoptosis in TNBC cells, we
examined the subcellular localization of Noxa in cells
treated with thapsigargin. Results shown in Fig. 5D, E
demonstrate that in untreated cells Noxa localized mainly
at the mitochondria as described in other cell types27.
Strikingly, mitochondrial levels of Noxa further increased
upon ER stress in TNBC cells as determined by both cell
fractionation and confocal microscopy (Fig. 5D and 5E),
and this was accompanied by Noxa-mediated down-
regulation of antiapoptotic Mcl-1 protein (Fig. S4E, S4F).
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Fig.4 Role of UPR sensors in ER stress-induced apoptosis. a MDA-MB231 and T47D breast cancer cells were treated with or without 100 nM
thapsigargin (TG) for different times. ATF4 and CHOP protein expression was assessed by western blotting. B) Cells were treated as in A) and
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quantiﬁed with respect to XBP1 unspliced (XBP1u). Error bars represent ±SEM from at least three independent experiments
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Overall, our data demonstrate that activation of the
PERK/ATF4/CHOP/TRAIL-R2 pathway together with
the enhanced Noxa levels at the mitochondria in response
to thapsigargin would be responsible for the greater sen-
sitivity of TNBC cells to ER stress-inducing agents.
FLIP regulates cell death upon ER stress in TNBC cells
cFLIP proteins are key inhibitors of the extrinsic
apoptotic pathway28. In addition, cFLIP downregulation
has been observed in different cell types following ER
stress11,29. To examine the role of cFLIP in the response of
TNBC cells to ER stress, we ﬁrst determined cFLIP levels
in several TNBC cell lines treated with thapsigargin for
different times (Fig. 6A). Although FLIP(S) levels declined
upon ER stress, FLIP(L) expression and apoptosis
remained unaffected (Fig. 6A) at times when TRAIL-R2
levels are already increased (Fig. 5A). To assess the
potential adaptive role of FLIP(L) in TNBC cells under-
going ER stress, we determined the apoptotic response to
thapsigargin in cells in which FLIP(L) was downregulated
with siRNA prior to thapsigargin treatment. Remarkably,
FLIP(L) silencing accelerated thapsigargin-induced apop-
tosis as compared to cells transfected with an irrelevant
control oligonucleotide (Fig. 6B). Furthermore, in FLIP(L)
knockdown cells, apoptosis induced by thapsigargin was
signiﬁcantly reduced if caspase-8 or TRAIL-R2/DR5
expression was also silenced (Fig. 6B), further demon-
strating the involvement of the extrinsic apoptotic
mechanism in this cell death process. These results were
also conﬁrmed in the TNBC MDA-MB468 cell line in
which the reduction in FLIP levels by siRNA signiﬁcantly
increased the sensitivity of these cells to thapsigargin
through activation of the extrinsic apoptotic pathway
(Fig. 6C). In addition, concomitant silencing of FLIP(L)
and proteins of the PERK branch of the UPR lead to
abrogation of ER stress-induced apoptosis, further sup-
porting the role of this UPR pathway in the activation of
the extrinsic apoptotic program in TNBC cells (Fig. 6D).
Overall, our data support that FLIP(L) might be playing a
role in maintaining the adaptive response of TNBC cells
during ER stress by preventing the early activation of
apoptosis through proapoptotic TRAIL-R2, thus favoring
cell survival and allowing adaptation to the stress-
inducing conditions.
Discussion
Pharmacological overactivation of the proapoptotic
branches of the UPR in tumor cells that are prone to ER
stress may represent a potentially relevant strategy to
therapeutically target these cells30. TNBC cells with a
basal-like and a mesenchymal phenotype show increased
synthesis and secretion of extracellular matrix proteins,
which results in an enhanced vulnerability to ER stress-
inducing agents16, although the underlying cell death
mechanism remains largely unknown. In this work, we
have investigated the role of the intrinsic and extrinsic
apoptotic pathways in the cell death process activated
upon ER stress in TNBC cells. Our results demonstrate
that in TNBC cells ER stress-inducing agents activates a
mitochondria-operated apoptotic process through both
the ATF4-dependent upregulation of proapoptotic
TRAIL-R2/DR5 and the activation of a Noxa-mediated
pathway.
Regarding the mechanism underlying the different sensi-
tivity to ER stress observed between TNBC and luminal
tumor cell lines, our data show marked differences in the
activation of the PERK and IRE1 branches of the UPR. In this
respect, our results indicate that differential activation of the
PERK/ATF4/CHOP pathway may be, at least in part,
responsible for the increased sensitivity of TNBC to ER stress-
inducing agents. In contrast to previous data suggesting a
certain role of the IRE1 branch in ER stress-induced apoptosis
in different cell types7,13,31, our results do not support a role of
IRE1 pathway in ER stress-induced apoptosis in TNBC cells.
Our ﬁndings are consistent with prior work in breast
epithelial cells expressing a constitutively active Her2/ErbB2
(see ﬁgure on previous page)
Fig. 5 Involvement of the PERK branch of the UPR in the activation of the extrinsic apoptotic pathway upon ER stress. a MDA-MB231, BT549
cells and T47D breast cancer cells were treated with or without thapsigargin (TG) 100 nM for 15 h and cell surface expression of TRAIL-R2 was
determined by ﬂow cytometry (left panel). Cells incubated with IgG-PE were used as a control for background ﬂuorescence of cells. (Right panel) Cells
were treated with 100 nM TG for the indicated times. TRAIL-R2 protein expression was assessed by western blotting. Data shown are representative of
three independent experiments. B) MDA-MB231 cells were transfected with siRNA against ATF4 or a scrambled oligonucleotide (SCR) for 30 h and then
treated with 50 nM TG for 15 or 24 h. ATF4, TRAIL-R2, and Noxa protein levels were assessed by western blotting. Data shown are representative of three
independent experiments. C) MDA-MB231 cells were either non-transfected (NT) or transfected with siRNAs for 30 h and then treated with 50 nM TG for
48 h. Apoptosis was measured by subG1 analysis, as described in the materials and methods section. Error bars represent SEM from at least three
independent experiments. **P < 0.01; n.s. not statistically signiﬁcant. ATF4, Caspase-8, and Noxa levels were assessed by western blotting.
D) MDA-MB231 cells were treated with or without (NT) 50 nM TG for 7 or 24 h. Noxa levels in cytosolic and mitochondrial fractions were assessed by
western blotting as described under materials and methods section. Caspase-3 and COX IV were used as controls of cytosolic and mitochondrial protein,
respectively E) MDA-MB231 cells were treated without (NT) or with 50 nM TG for 7 h and then processed for immunoﬂuorescence analysis with Noxa
antibody. Mitochondria were stained with MitoTracker. Representative confocal microscopic images are shown. Quantiﬁcation of Noxa–mitochondria
colocalization was performed with the Metamorph software. Error bars represent SEM from three independent experiments
(100 cells/condition and experiment).*P < 0.05
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oncogene in which ER stress-induced apoptosis was inde-
pendent of the IRE1 pathway11. Collectively, these data sug-
gest that IRE1 function in the regulation of apoptosis after
sustained ER stress may be cell type speciﬁc.
Transcription factors ATF4 and CHOP are important
effectors in the activation of apoptosis following ER stress
in different cell types through the regulation of the
expression levels of various members of the Bcl-2 family.
Thus activation of the ATF4/CHOP axis can either reduce
Bcl-2 levels32 or increase the expression of some proa-
poptotic members of the Bcl-2 family, such as Bim, Puma,
and Noxa9,19,26,33. Instead, our results show that in TNBC
cells the PERK/ATF4/CHOP pathway is licensing apop-
tosis mainly through activation of the TRAIL-R2/caspase-
8 pathway. These data are consistent with previous studies
demonstrating that ER stress induces cell death by
CHOP-mediated upregulation of TRAIL-R2 expression,
leading to a ligand-independent, intracellular death-
inducing signaling complex formation and caspase-8
activation11–13. In this respect, ectopic expression of
TRAIL-R2 is sufﬁcient to induce apoptosis in the absence
of ligand34, most likely by the homotypic association of
receptors through PLAD-like domains in TRAIL-R235.
Regarding the activation of the intrinsic apoptotic
pathway upon ER stress in TNBC cells, our observations
clearly demonstrate a key role of BH3-only protein Noxa
in mediating apoptosis in a redundant manner with
TRAIL-R2/caspase-8 activation. TNBC cells show ele-
vated basal levels of Noxa with a preferential localization
in mitochondria that increases upon ER stress. Although
transcriptional upregulation of Noxa expression has been
proposed as a mechanism involved in apoptosis induced
by ER stress in tumor cells26, posttranslational mechan-
isms may also be important19,36. Indeed, cytosolic reten-
tion of Noxa by phosphorylation has been reported to
suppress its proapoptotic function36,37. Our results also
demonstrate a Noxa-dependent downregulation of Mcl-1
in response to ER stress. Accordingly, Noxa has been
shown to speciﬁcally interact with antiapoptotic Mcl-1 to
induce its degradation by the proteasome38. Together, our
data suggest that, under chronic ER stress in TNBC cells,
upregulation of Noxa levels at the mitochondria will
antagonize Mcl-1 function by promoting its proteasomal
degradation, leading to mitochondria outer membrane
permeabilization and the release of apoptogenic factors39.
Both FLIP(L) and FLIP(S) are short-lived inhibitory
proteins40 expressed at high levels in breast cancers41.
Evidences from different studies have indicated that reg-
ulation of FLIP expression levels is a key event in the
mechanism controlling sensitivity of tumor cells to death
receptor-mediated apoptosis. Thus selective suppression
of FLIP expression in breast tumor cells induces caspase-
8-dependent apoptosis both in vitro and in vivo42 and
sensitizes these cells to TRAIL43. Our results reveal for
the ﬁrst time a key role of FLIP(L) in the preservation of
cell viability under ER stress in TNBC cells and point at
the deregulation of the mechanisms controlling FLIP
levels44 as an essential event in the process leading to
apoptosis under chronic ER stress11.
To facilitate their migration, basal TNBC cells with a
mesenchymal phenotype must secrete matrix proteases
and scaffolding proteins to remodel the extracellular
matrix. Secretory phenotype of mesenchymal TNBC cells
relies on the basal activation of the PERK branch of the
UPR as part of an adaptive response to preserve cell via-
bility16. In this context, FLIP levels may play a key role in
cell fate decisions as maintenance of FLIP levels will
prevent early activation of death receptor-activated
apoptotic pathway, thus providing time for the cell to
adapt to the stressful conditions of the microenvironment
(Fig. 7). However, if the stress persists, FLIP(L) levels may
decrease leading to activation of the extrinsic apoptotic
pathway, which, together with the activation of the Noxa-
regulated intrinsic pathway, will execute the apoptosis
program induced by the UPR.
Materials and methods
Cell culture
MDA-MB231 cells were maintained in RPMI medium
supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, penicillin (50 U/ml) and streptomycin (50 μg/
ml). T47D cells were grown in RPMI medium supple-
mented with 10% fetal bovine serum, 2 mM L-glutamine,
(see ﬁgure on previous page)
Fig. 6 FLIP(L) controls ER stress-induced apoptosis. a TNBC cells lines MDA-MB231, BT549, and MBA-MB468 were treated with 50 nM
thapsigargin (TG) for the indicated times. FLIP protein levels were assessed by western blotting. B) MDA-MB231 TNBC cells were either non-
transfected (NT) or transfected with siRNAs or SCR for 30 h and then treated with TG for 24 h. Apoptosis was measured by subG1 analysis. Error bars
represent SEM from at least three independent experiments. *P < 0.05; ***P < 0.001. FLIP, Caspase-8, and TRAIL-R2 protein levels were assessed by
western blotting. C) MDA-MB468 cells were transfected as in B), treated with TG for 48 h and then apoptosis was measured. Error bars represent SEM
from at least three independent experiments. *P < 0.05; **P < 0.01. FLIP, Caspase-8, and TRAIL-R2 protein levels were assessed by western blotting.
D) MDA-MB231 cells were either NT or transfected with siRNAs for 30 h and then treated with TG for 24 h. Apoptosis was measured by subG1
analysis. Error bars represent SEM from at least three independent experiments. *P < 0.05; ***P < 0.001. FLIP, ATF4, and CHOP protein levels were
assessed by western blotting after 15 h of TG treatment
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5mM glucose, penicillin (50 U/ml), and streptomycin (50
μg/ml). MDA-MB468, MDA-MB175 VII, and BT549 cells
were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) medium supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, penicillin (50 U/ml), and
streptomycin (50 μg/ml). BT20 and MDA-MB436 cells
were maintained in DMEM/F12 medium supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, peni-
cillin (50 U/ml), and streptomycin (50 μg/ml). Cells were
grown at 37 °C in a 5% CO2-humidiﬁed, 95% air
incubator.
Reagents and antibodies
Tunicamycin, thapsigargin, 4,6-diamidino-2-pheny-
lindole (DAPI), and anti-α-tubulin were from Sigma-
Aldrich (St. Louis, MO, USA). Anti-caspase 8 antibody
was generously provided by Dr. Gerald Cohen (Leicester
University, UK). Anti-FADD, anti-Bid, anti-caspase-3, and
anti-IgG-PE antibodies were purchased from BD
Bioscience (Erembodegem, Belgium). Anti-caspase 9 was
purchased from MBL Life Science (Nagoya, Japan). Anti-
TRAIL-R2-PE monoclonal antibody for surface receptor
analysis was from Biolegend (San Diego, CA, USA). Anti-
ATF4 and anti-GAPDH antibodies were from Santa Cruz
Technology (Santa Cruz, CA, USA). Anti-CHOP, anti-
TRAIL, anti-cleaved caspase-3, anti-cleaved caspase-8,
anti-cleaved-caspase-9, anti-Bcl-XL, and anti-IRE1 anti-
bodies were from Cell Signaling Technology (Temecula,
CA, USA). Anti-TRAIL-R1 and anti-TRAIL-R2 antibodies
were from R&D system (Minneapolis, USA). Anti-FLIP
(NF6) antibody was from Adipogen (San Diego, CA, USA).
Anti-Noxa and anti-Bim were from Calbiochem (Darm-
stadt, Germany) Anti-Noxa antibody for immuno-
ﬂuorescence was from Abcam (Cambrige, UK). Donkey
anti-rabbit Cy3 and donkey anti-mouse Alexa488 second-
ary antibodies were from Jackson ImmunoResearch (West
Grove, PA, USA). Horseradish peroxidase or ﬂuorescein
isothiocyanate-conjugated secondary antibodies, goat
antimouse, and goat anti-rabbit antibodies were from
DAKO (Cambridge, UK). DTT was from Roche (Basel,
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Fig. 7 Schematic overview of the proposed mechanism of ER stress-induced apoptosis in TNBC cells. ER stress induces cell death in TNBC
cells through a FLIP(L)-regulated pleiotropic mechanism, which involves both caspase-8-dependent and -independent apoptotic pathways
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Switzerland). Q-VD was from Apexbio (Hsinchu, Taiwan).
Z-VAD-fmk was from Bachem AG (Bubendorff, Switzer-
land). MitoTracker was purchased from Fisher Scientiﬁc
(Waltham, MA, USA).
Determination of apoptosis
Cells (3× 105/well) were treated in 6-well plates.
After treatment, hypodiploid apoptotic cells were
detected by ﬂow cytometry according to published
procedures11.
Analysis of TRAIL receptors by ﬂow cytometry
Cells were detached with trypsin solution and resus-
pended in growth media. After incubation for 15 min
under cell culture conditions (37 °C in a 5% CO2-humi-
diﬁed, 95% air incubator), cells were washed with ice-cold
phosphate-buffered saline (PBS) and resuspended in PBS.
Cells were then labeled either with 5 μg/ml of anti-
TRAIL-R2-PE or an IgG-PE control antibody for 30 min
on ice and darkness. Quantitative analysis of the receptor
cell surface expression was carried out in a FACSCalibur
cytometer using the Cell Quest Software (Becton Dick-
inson, Mountain View, CA, USA).
Immunoﬂuorescence analysis
Cells were grown on coverslips, ﬁxed in paraformalde-
hyde 4% at room temperature for 5 min and then per-
meabilized with 100% methanol at −20 °C for 5 min. Cells
were incubated with primary antibodies at 4 °C overnight,
washed with 0.1% PBS-Tween, and incubated with the
appropriate ﬂuorescent secondary antibody for 1 h. Nuclei
were stained with DAPI (1 μg/ml) after secondary
labeling.
Confocal microscopy and image analysis
Confocal images were captured using TCS SP5 confocal
Leica laser scanning systems equipped with DMI60000
microscope. Image processing was carried out using the
Leica (LAS) and Adobe Photoshop software. For pre-
sentation, whole images were adjusted for intensity level,
contrast, and/or brightness. Quantiﬁcation of intracellular
Noxa or mitochondria was performed using the Meta-
morph Ofﬂine software, measuring average intensity of
Noxa over mitochondria.
Immunoblot analysis of proteins
Cells (3× 105) were washed with PBS and lysed in TR3
lysis buffer (3% sodium dodecyl sulfate (SDS), 10% Gly-
cerol, 10 mM Na2HPO4). Then lysates were sonicated and
protein content was measured with the Bradford reagent
(Bio-Rad Laboratories, USA), before adding Laemmli
sample buffer. Proteins were resolved on SDS-
polyacrylamide minigels and detected as described pre-
viously11. Tubulin and GAPDH (glyceraldehyde 3-
phosphate dehydrogenase) were used as protein-loading
controls.
RNA interference
siRNAs against ATF4 (5ʹ-GCCUAGGUCUCUUAG
AUGA-3ʹ), ATF6 (5ʹ-GCAACCAAUUAUCAGUUUA-3ʹ),
Bim (5ʹ-GCAACCUUCUGAUGUAAGU-3ʹ), Casp8 (5ʹ-
GGAGCUGCUCUUCCGAAUU-3ʹ), BID (5ʹ-AGAC
AAUGUUAAACUUAUA-3ʹ), CHOP pool (5ʹ-AGGGAG
AACCAGGAAACGGAA-3ʹ, 5ʹ-ACGGCUCAAGCAGGA
AAUCGA-3ʹ, 5ʹ-AAGGAAGUGUAUCUUCAUACA-3ʹ, 5ʹ-
CAGCUUGUAUAUAGAGAUUGU-3ʹ), FADD (5ʹ-GAAG
ACCUGUGUGCAGCAU-3ʹ), FLIP(L) (5ʹ-CCUAGGAAU
CUGCCUGAUA-3ʹ), Ire1 (5ʹ-GCGUCUUUUACUACGUA
AU-3ʹ), Noxa (5ʹ-GGUGCACGUUUCAUCAAU3ʹ), Puma
(5ʹ-GGAGGGUCCUGUACAAUCU-3ʹ), TRAIL-R1 (5ʹ-GG
UAACUUUCCGGAAUGACA-3ʹ), TRAIL-R2 (5ʹ-GAU
CCCUUGUGCUCGUUGUC-3ʹ), TRAIL#1 (5ʹ-GCAGCU
CACAUAACUGGGA-3ʹ), TRAIL#2 (5ʹ-GAAUAUGGA
CUCUAUUCCA-3ʹ), and non-targeting scrambled oligo-
nucleotide (5ʹ-GAGCGCUAGACAAUGAAG-3ʹ) were syn-
thesized by Sigma (St. Louis, MO). Cells were transfected
with siRNAs using DharmaFECT-1 (Dharmacon) as
described by the manufacturer. After 6 h, transfection
medium was replaced with regular medium and cells were
further incubated for 24 h before further analysis.
Real-time quantitative PCR (qPCR)
mRNA expression was analyzed in triplicate by reverse
transcriptase-qPCR on the ABI Prism7500 sequence
detection system using predesigned assay-on-demand pri-
mers and probes (Applied Biosystems). Hypoxanthine-
guanine phosphoribosyltransferase (HPRT1 Hs0100
3267_m1) was used as an internal control and mRNA
expression levels of ATF6, TRAIL, and Puma were given
as fraction of mRNA levels in control cells. Primers and
probes used were: ATF6 (Hs00232586_m1), TRAIL
(Hs00921974_m1), and Puma (Hs0024075_m1).
Retroviral vectors and virus production
pbabe-BCL-xL was a gift from Dr. Cristina Muñoz
(IDIBELL, Barcelona, Spain). Retroviruses for protein
overexpression were produced by transfection of
HEK293-T cells by the calcium phosphate method with
the corresponding retroviral vectors. Retrovirus-
containing supernatants were collected 48 h after trans-
fection and concentrated by ultracentrifugation at 22,000
rpm for 90min at 4 °C.
Retro transcription-multiplex ligand probe-dependent
ampliﬁcation
RNA was isolated from cultured 3–5× 106 cells by the
RNeasy Micro Kit (Qiagen GmbH, Hilden, Germany)
according to the manufacturer’s protocol. RNA was
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analyzed by RT-MLPA using SALSA MLPA KIT R011-C1
Apoptosis mRNA from MRC-Holland (Amsterdam, The
Netherlands) for the simultaneous detection of 40 mRNA
molecules, including apoptosis-related genes. In brief,
RNA samples (200 ng total RNA) were ﬁrst reverse
transcribed using a gene-speciﬁc primer mix. The
resulting cDNA was annealed overnight at 60 °C to the
RT-MLPA probe mix. Annealed oligonucleotides were
ligated by adding Ligase-65 (MRC-Holland) and incu-
bated at 54 °C for 15min. Ligation products were ampli-
ﬁed by PCR (35 cycles, 30 s at 95 °C; 30 s at 60 °C, and 1
min at 72 °C) with one unlabeled and one FAM-labeled
primer. The ﬁnal PCR fragments ampliﬁed were separated
by capillary electrophoresis on a 96-capillary ABI-Prism
3730XL Genetic Analyzer (Applied Biosystems/Hitachi,
Carlsbad, CA, USA). Peak area and height were measured
using the GeneMapper v3.0 analysis software (Applied
Biosystems). Ratios of individual peaks relative to the sum
of all peaks were calculated, resulting in the relative
abundance of mRNAs of the genes of interest and nor-
malized with respect to β2-microglobulin.
Subcellular fractionation
After treatment, cells washed with PBS and lysed in
30 μl ice-cold lysis buffer (80mM KCl, 250 mM sucrose,
500 μg/ml digitonin and protease inhibitors in PBS). Cell
lysates were centrifuged for 5 min at 10,000× g to sepa-
rate the supernatant (cytosolic fraction) and pellet
(mitochondria-containing fraction). Proteins from the
supernatant and pellet were resolved on SDS-15% poly-
acrylamide gel electrophoresis, and Noxa, COX IV, and
Casp3 was determined by western blotting analysis.
Quantiﬁcation of Mcl-1 and XBP1
Mcl1 and XBP1 were quantiﬁed with the Image Quant
5.2. software. Results were normalized to the loading
control and referred to the untreated condition.
Statistical analysis
All data are presented as the mean± SEM of at least
three independent experiments. The differences among
different groups were determined by Student’s t-test. P<
0.05 was considered signiﬁcant.
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